These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9663622)

  • 1. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.
    Heimer R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S65-73. PubMed ID: 18207726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
    Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
    Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities.
    Behrends CN; Li CS; Gibson DR
    Subst Use Misuse; 2017 Jul; 52(9):1151-1159. PubMed ID: 28557553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.
    Kral AH; Anderson R; Flynn NM; Bluthenthal RN
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1307-12. PubMed ID: 15385739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.
    Bluthenthal RN; Anderson R; Flynn NM; Kral AH
    Drug Alcohol Depend; 2007 Jul; 89(2-3):214-22. PubMed ID: 17280802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
    Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS
    Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
    Iversen J; Topp L; Wand H; Maher L
    Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
    Watters JK; Estilo MJ; Clark GL; Lorvick J
    JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: syringe exchange programs--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(27):673-6. PubMed ID: 16015218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.
    Junge B; Vlahov D; Riley E; Huettner S; Brown M; Beilenson P
    J Am Pharm Assoc (Wash); 1999; 39(1):17-22. PubMed ID: 9990182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.
    Gleghorn AA; Wright-De Agüero L; Flynn C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S30-6. PubMed ID: 9663621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.